|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2017-08-22 12:35:01 CEST 2017-08-22 12:35:01 CEST Biohit Oyj - Managers' transactionsBiohit Oyj - Managers' TransactionsBiohit Oyj - Managers' Transactions, August 22, 2017 at 1:35 pm local time (EEST)
Biohit Oyj has received the following notification.
Additional information:
CEO Semi Korpela, Biohit Oyj
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|